Učitavanje...
Erythropoietin or darbepoetin for patients with cancer
BACKGROUND: Anaemia associated with cancer and cancer therapy is an important clinical factor in the treatment of malignant diseases. Therapeutic alternatives are recombinant human erythropoiesis stimulating agents (ESAs) and red blood cell transfusions. OBJECTIVES: To assess the effects of ESAs to...
Spremljeno u:
| Izdano u: | Cochrane Database Syst Rev |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2012
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8145276/ https://ncbi.nlm.nih.gov/pubmed/23235597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003407.pub5 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|